<p>Forest plots of all studies reporting on first trimester (a) PAPP-A MoM levels and (b) free β-hCG MoM levels for women with and without gestational diabetes mellitus.</p
Objective: We examined whether first trimester aneuploidy and pre-eclampsia screening markers predic...
Objective: We investigated the utility of maternal fetuin-A, N-terminal proatrial natriuretic peptid...
Objective. To examine the value of first trimester matemal serum flee β human chorionic gonadotrophi...
Biomarkers commonly assessed in prenatal screening have been associated with a number of adverse per...
<div><p>Biomarkers commonly assessed in prenatal screening have been associated with a number of adv...
Objective: Serum markers measured early in pregnancy have been associated with the later diagnosis o...
Objectives To evaluate the first trimester maternal biomarkers for early pregnancy prediction of ges...
AimsTo evaluate the clinical utility of first and second trimester prenatal screening biomarkers for...
Background-The first trimester combined test (FTCT) is an effective screening tool to estimate the r...
Detecting pregnant women at risk of diabetes in first months can help them by early intervention for...
Gestational diabetes is recognised to be an increasingly common and treatable cause of maternal and ...
Objective: To determine whether first-trimester measurements of maternal serum PAPP-A and free beta ...
Introduction: The purpose of the present study was to compare maternal serum betatrophin levels duri...
OBJECTIVE—Predictors of gestational diabetes mellitus (GDM) have been widely studied, but few studie...
Objectives: Screening and diagnosis of gestational diabetes (GDM) has been a source of controversy. ...
Objective: We examined whether first trimester aneuploidy and pre-eclampsia screening markers predic...
Objective: We investigated the utility of maternal fetuin-A, N-terminal proatrial natriuretic peptid...
Objective. To examine the value of first trimester matemal serum flee β human chorionic gonadotrophi...
Biomarkers commonly assessed in prenatal screening have been associated with a number of adverse per...
<div><p>Biomarkers commonly assessed in prenatal screening have been associated with a number of adv...
Objective: Serum markers measured early in pregnancy have been associated with the later diagnosis o...
Objectives To evaluate the first trimester maternal biomarkers for early pregnancy prediction of ges...
AimsTo evaluate the clinical utility of first and second trimester prenatal screening biomarkers for...
Background-The first trimester combined test (FTCT) is an effective screening tool to estimate the r...
Detecting pregnant women at risk of diabetes in first months can help them by early intervention for...
Gestational diabetes is recognised to be an increasingly common and treatable cause of maternal and ...
Objective: To determine whether first-trimester measurements of maternal serum PAPP-A and free beta ...
Introduction: The purpose of the present study was to compare maternal serum betatrophin levels duri...
OBJECTIVE—Predictors of gestational diabetes mellitus (GDM) have been widely studied, but few studie...
Objectives: Screening and diagnosis of gestational diabetes (GDM) has been a source of controversy. ...
Objective: We examined whether first trimester aneuploidy and pre-eclampsia screening markers predic...
Objective: We investigated the utility of maternal fetuin-A, N-terminal proatrial natriuretic peptid...
Objective. To examine the value of first trimester matemal serum flee β human chorionic gonadotrophi...